SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-029621
Filing Date
2022-08-24
Accepted
2022-08-24 18:15:33
Documents
1
Period of Report
2022-08-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5499
  Complete submission text file 0000899243-22-029621.txt   7126
Mailing Address C/O PROTAGONIST THERAPEUTICS, INC. 521 COTTONWOOD DRIVE, SUITE 100 MILPITAS CA 95035
Business Address
PATEL DINESH V PH D (Reporting) CIK: 0001120477 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-37852 | Film No.: 221192515

Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Issuer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations